Omega Therapeutics Announced Presentation Of New Preclinical Data Demonstrating Durable, Tunable Bidirectional Regulation Of Gene Expression In Cellular Models At Pre-transcriptional Level At The American Society Of Gene And Cell Therapy Annual Meeting

5/8/24 7:13:16 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Get the next $OMGA alert in real time by email

Get the next $OMGA alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OMGA

Date	Price Target	Rating	Analyst
6/18/2024	$12.00	Outperform	Raymond James
5/25/2023	$18.00 → $15.00	Buy	Jefferies
12/8/2022	$11.00	Buy	H.C. Wainwright
9/23/2022	$12.00	Buy	Chardan Capital Markets
8/24/2021	$36.00	Outperform	Wedbush
8/24/2021	$30.00	Buy	Jefferies
8/24/2021	$30.00	Overweight	Piper Sandler
8/24/2021	$22.00	Neutral	Goldman Sachs

More analyst ratings

$OMGA
Leadership Updates

Live Leadership Updates

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
CAMBRIDGE, Masss. and LONDON, Oct. 23, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced that Junaid Bajwa, M.D., has joined its London office as Senior Partner and Head of United Kingdom. In this role, Dr. Bajwa will play an integral role in advancing new strategic opportunities and partnerships for Flagship and its ecosystem of companies in the United Kingdom and throughout Europe. Dr. Bajwa will also serve as Science Partner for Pioneering Intelligence, Flagship's strategic initiative that is building unique AI/ML knowledge to accelerate innovation across the ecosystem.
10/23/24 8:00:00 AM ET
$FHTX
$MRNA
$OMGA
$SANA
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions
CAMBRIDGE, Mass., Oct. 9, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced that Paul Parker has joined as Managing Partner, Capital Solutions and Value Realization. In this role, Parker will lead all capital solutions efforts at Flagship, driving portfolio value realization, fundraising activities, and building and managing Flagship's relationships with Limited Partners as well as strategic and financial investors. He will also play a key role on Flagship's senior leadership team, helping drive value, impact, and effectiveness across the organization.
10/9/24 7:00:00 AM ET
$FHTX
$MRNA
$OMGA
$SANA
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
CAMBRIDGE, Mass., Oct. 3, 2024 /PRNewswire/ -- Invaio Sciences, a Flagship Pioneering bioplatform company focused on accelerating the leap to nature-positive agriculture, today announced the appointment of André Andonian as the new Chairman of its Board of Directors. Robert Berendes has decided to step down after serving as Chairman of the Board since 2019 and will continue to serve on the board of Invaio. Andonian is Chair of Asia Pacific and Strategic Advisor at Flagship Pioneering, where he and Ignacio Martinez are responsible partners for Invaio. He is also Senior Partner
10/3/24 8:00:00 AM ET
$FHTX
$MRNA
$OMGA
$SANA
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
CAMBRIDGE, Masss. and LONDON, Oct. 23, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced that Junaid Bajwa, M.D., has joined its London office as Senior Partner and Head of United Kingdom. In this role, Dr. Bajwa will play an integral role in advancing new strategic opportunities and partnerships for Flagship and its ecosystem of companies in the United Kingdom and throughout Europe. Dr. Bajwa will also serve as Science Partner for Pioneering Intelligence, Flagship's strategic initiative that is building unique AI/ML knowledge to accelerate innovation across the ecosystem.
10/23/24 8:00:00 AM ET
$FHTX
$MRNA
$OMGA
$SANA
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
CAMBRIDGE, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (NASDAQ:OMGA) ("Omega"), a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines, today announced it will share new preclinical data at three upcoming scientific meetings. "These preclinical results build upon the foundation of data we have shared to date and expand our confidence in the ability of epigenomic controllers to upregulate or downregulate the expression of one or more genes," said Mahesh Karande, President and Chief Executive Officer of Omega Therapeutics. "More broadly, we believe these upcoming presentations further demonstrate the p
10/15/24 8:00:00 AM ET
$OMGA
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions
CAMBRIDGE, Mass., Oct. 9, 2024 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced that Paul Parker has joined as Managing Partner, Capital Solutions and Value Realization. In this role, Parker will lead all capital solutions efforts at Flagship, driving portfolio value realization, fundraising activities, and building and managing Flagship's relationships with Limited Partners as well as strategic and financial investors. He will also play a key role on Flagship's senior leadership team, helping drive value, impact, and effectiveness across the organization.
10/9/24 7:00:00 AM ET
$FHTX
$MRNA
$OMGA
$SANA
Biotechnology: Pharmaceutical Preparations
Health Care
Biotechnology: Biological Products (No Diagnostic Substances)

Omega Therapeutics Announced Presentation Of New Preclinical Data Demonstrating Durable, Tunable Bidirectional Regulation Of Gene Expression In Cellular Models At Pre-transcriptional Level At The American Society Of Gene And Cell Therapy Annual Meeting

Chat with this insight

Recent Analyst Ratings for $OMGA

$OMGA Leadership Updates

Live Leadership Updates

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions

Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors

$OMGA Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by Omega Therapeutics Inc. (Amendment)

SEC Form SC 13G/A filed by Omega Therapeutics Inc. (Amendment)

SEC Form SC 13G/A filed by Omega Therapeutics Inc. (Amendment)

$OMGA SEC Filings

$OMGA Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Omega Therapeutics Inc. filed SEC Form 8-K: Leadership Update

Omega Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

SEC Form 10-Q filed by Omega Therapeutics Inc.

SEC Form 4 filed by Director Rosiello Robert L.

SEC Form 3 filed by new insider Rosiello Robert L.

SEC Form 4 filed by Director Young Richard A

$OMGA Market Insights

Live Market Insights

Omega Therapeutics shares are trading higher after Raymond James initiated coverage on the stock with an Outperform rating and announced a $12 price target.

Expert Ratings For Omega Therapeutics

Raymond James Initiates Coverage On Omega Therapeutics with Outperform Rating, Announces Price Target of $12

$OMGA Financials

Live finance-specific insights

Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial

Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial on September 26

$OMGA Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

$OMGA Press Releases

Fastest customizable press release news feed in the world

Raymond James initiated coverage on Omega Therapeutics with a new price target

Jefferies resumed coverage on Omega Therapeutics with a new price target

H.C. Wainwright initiated coverage on Omega Therapeutics with a new price target

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings

Flagship Pioneering Announces Appointment of Paul Parker as Managing Partner, Leading Capital Solutions

Recent Analyst Ratings for
$OMGA

$OMGA
Leadership Updates

$OMGA
Large Ownership Changes

$OMGA
SEC Filings

$OMGA
Insider Trading

$OMGA
Market Insights

$OMGA
Financials

$OMGA
Analyst Ratings

$OMGA
Press Releases